[XENE] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
08-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -45.99%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 6,829 0 311 1,803 15,577 28,370 27,356 -20.64%
PBT -41,618 -34,497 -30,704 -22,997 -15,752 13,018 12,032 -
Tax -23 4,913 -1,871 -1,820 -1,038 0 64 -
NP -41,595 -34,497 -30,704 -22,997 -15,752 13,018 12,032 -
Tax Rate - - - - - 0.00% -0.53% -
Total Cost 48,424 34,497 31,015 24,800 31,329 15,352 15,324 21.12%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -609.09 0.00 -9,872.67 -1,275.49 -101.12 45.89 43.98 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -1.60 -1.78 -1.71 -1.48 -1.10 4.11 0.42 -
EPS Diluted -1.60 -1.78 -1.71 -1.48 -1.10 3.28 0.39 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.